Epigenomics AG
EPGNFOTCHealthcare● Active
$1.12
+$0.00(+0.00%)
Market Cap$982183
P/E Ratio—
52W High$1.12
52W Low$0.79
Epigenomics AG (EPGNF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EPGNF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.02M | $0.00M | $0.34M | $0.48M | $6.20M |
| Cost of Revenue | $0.00M | $0.01M | $0.06M | $0.12M | $0.14M |
| Gross Profit | $0.00M | ($0.01M) | $0.28M | $0.36M | $6.07M |
| Gross Margin %(computed) | 0.00% | — | 83.22% | 75.26% | 97.81% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $6.19M | $3.11M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $0.36M | $1.13M | $4.78M | $12.42M | $8.42M |
| Operating Income | ($0.34M) | ($1.14M) | ($4.18M) | ($12.05M) | ($2.35M) |
| Operating Margin %(computed) | — | — | — | — | -37.95% |
| Interest Income | $0.04M | $0.04M | $0.59M | $0.10M | $0.01M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.15M | $0.05M |
| Income Before Tax | ($0.31M) | ($3.35M) | ($4.46M) | ($12.10M) | ($2.41M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($0.08M) | $0.02M |
| Net Income | ($0.31M) | ($3.35M) | ($4.46M) | ($12.02M) | ($2.43M) |
| Net Margin %(computed) | — | — | — | — | -39.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.36 | $-3.82 | $-5.23 | $-14.78 | $-4.33 |
| Wtd Avg Shares | 0.88M | 0.88M | 0.85M | 0.81M | 0.56M |
| EBITDA | ($0.34M) | ($3.34M) | ($3.61M) | ($11.22M) | ($1.94M) |
| EBITDA Margin %(computed) | — | — | — | — | -31.26% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · M
Explore more Epigenomics AG data
About Epigenomics AG (EPGNF) Income Statement
Epigenomics AG (EPGNF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EPGNF reported revenue of $0.00B, gross profit of $0.00B (gross margin 0.00%), and net income of ($0.00B) — a net profit margin of -1308.39%.
Frequently asked questions
EPGNF · 4 questionsEpigenomics AG (EPGNF) reported revenue of $0.00B for 2025, up —% year-over-year.
EPGNF revenueEPGNF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09